WORCESTER, Mass. and BEIRUT, Lebanon, May 14, 2009 (GLOBE NEWSWIRE) -- At a press conference earlier today in Beirut, with Lebanese Minister of Health H.E. Muhammad Jawad Khalifah, Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, together with Benta s.a.l. (www.bpi.com.lb), the Company’s importation, marketing, distribution and sales sub-licensee in Lebanon, announced the launch of commercial retail sales of Generex Oral-lyn(tm) in Lebanon. The product has been approved for importation and commercial marketing and sale in Lebanon by the Ministry of Public Health, and will be marketed and sold for the treatment of patients with Type-1 and Type-2 diabetes in Lebanon.
